12:39 Wed 01 Jul 2020
Alliance Pharma PLC - Block Listing Six Monthly Return
For immediate release |
|
("Alliance" or the "Company")
Block Listing Six Monthly Return
|
|
|||
Names of schemes: |
a) The b) The c) The |
|||
Period of return: |
From: |
|
To: |
|
Number of securities originally admitted at date of admission: |
25,000,000 ordinary shares of 1p each |
|||
Balance of unallotted securities under schemes from previous return: |
a) 549,074 b) 6,111,334 c) 637,576 |
|||
Plus: The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for): |
a) 160,000 b) Nil c) 14,840,000 |
|||
Less: Number of securities issued/allotted under schemes during period: |
a) 352,538 b) 748,556 c) 554,351 |
|||
Equals: Balance under schemes not yet issued/allotted at end of period: |
a) 356,536 b) 5,362,778 c) 14,923,223 |
|||
|
|
Telephone number of contact: |
Tel. +44 (0)1249 705166 |
For further information:
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
Buchanan + 44 (0) 20 7466 5000
Mark Court / Hannah Ratcliff
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Freddie Barnfield / Huw Jeremy
Corporate Broking: James Black
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar
About Alliance Pharma
We currently own or license the rights to around 90 consumer healthcare products and pharmaceuticals, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused on a small number of brands with significant international or multi-territory reach. The remainder of the portfolio comprises products which are sold in a limited number of local markets and require little or no promotional investment.
Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.
For more information on Alliance, please visit our website: http://www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE